載入...
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk
Rivaroxaban is a direct factor Xa inhibitor that is widely available to reduce the risk of stroke or systemic embolism in patients with nonvalvular atrial fibrillation and one or more risk factors for stroke. Rivaroxaban provides practical advantages compared with warfarin and other vitamin K antago...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3956810/ https://ncbi.nlm.nih.gov/pubmed/24648742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S55246 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|